Literature DB >> 24936309

Pulmonary function derangements in isolated or predominant mitral stenosis - Preoperative evaluation with clinico-hemodynamic correlation.

Usha T Parvathy1, Rajesh Rajan1, Alexander Georgevich Faybushevich1.   

Abstract

INTRODUCTION: It is well known that mitral stenosis (MS) is complicated by pulmonary hypertension (PH) of varying degrees. The hemodynamic derangement is associated with structural changes in the pulmonary vessels and parenchyma and also functional derangements. This article analyzes the pulmonary function derangements in 25 patients with isolated/predominant mitral stenosis of varying severity. AIMS: THE AIM OF THE STUDY WAS TO CORRELATE THE PULMONARY FUNCTION TEST (PFT) DERANGEMENTS (DONE BY SIMPLE METHODS) WITH: a) patient demographics and clinical profile, b) severity of the mitral stenosis, and c) severity of pulmonary artery hypertension (PAH) and d) to evaluate its significance in preoperative assessment. SUBJECTS AND METHODS: This cross-sectional study was conducted in 25 patients with mitral stenosis who were selected for mitral valve (MV) surgery. The patients were evaluated for clinical class, echocardiographic severity of mitral stenosis and pulmonary hypertension, and with simple methods of assessment of pulmonary function with spirometry and blood gas analysis. The diagnosis and classification were made on standardized criteria. The associations and correlations of parameters, and the difference in groups of severity were analyzed statistically with Statistical Package for Social Sciences (SPSS), using nonparametric measures.
RESULTS: THE SPIROMETRIC PARAMETERS SHOWED SIGNIFICANT CORRELATION WITH INCREASING NEW YORK HEART ASSOCIATION (NYHA) FUNCTIONAL CLASS (FC): forced vital capacity (FVC, r = -0.4*, p = 0.04), forced expiratory volume in one second (FEV1, r = -0.5*, p = 0.01), FEV1/FVC (r = -0.44*, p = 0.02), and with pulmonary venous congestion (PVC): FVC (r = -0.41*, p = 0.04) and FEV1 (r = -0.41*, p = 0.04). Cardiothoracic ratio (CTR) correlated only with FEV1 (r = -0.461*, p = 0.02) and peripheral saturation of oxygen (SPO2, r = -0.401*, p = 0.04). There was no linear correlation to duration of symptoms, mitral valve orifice area, or pulmonary hypertension, except for MV gradient with PCO2 (r = 0.594**, p = 0.002). The decreased oxygenation status correlated significantly with FC, CTR, PVC, and with deranged spirometry (r = 0.495*, p = 0.02).
CONCLUSIONS: PFT derangements are seen in all grades of severity of MS and correlate well with the functional class, though no significant linear correlation with grades of severity of stenosis or pulmonary hypertension. Even the early or mild derangements in pulmonary function such as small airway obstruction in the less severe cases of normal or mild PH can be detected by simple and inexpensive methods when the conventional parameters are normal. The supplementary data from baseline arterial blood gas analysis is informative and relevant. This reclassified pulmonary function status might be prognostically predictive.

Entities:  

Keywords:  mitral stenosis; pulmonary function test; pulmonary hypertension

Year:  2014        PMID: 24936309      PMCID: PMC4047508          DOI: 10.1556/IMAS.6.2014.2.4

Source DB:  PubMed          Journal:  Interv Med Appl Sci        ISSN: 2061-1617


  16 in total

1.  Effect of closed mitral valvotomy on spirometric pulmonary function tests in mitral stenosis.

Authors:  P P Kadam; S H Pantvaidya; S R Jagtap; K D Rajgor
Journal:  J Postgrad Med       Date:  1997 Apr-Jun       Impact factor: 1.476

2.  Partial improvement in pulmonary function after successful percutaneous balloon mitral valvotomy.

Authors:  J A Gómez-Hospital; A Cequier; P V Romero; C Cañete; C Ugartemendia; J Mauri; E Esplugas
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

3.  Convenient method of evaluating pulmonary ventilatory function with a single breath test.

Authors:  W F MILLER; N WU; R L JOHNSON
Journal:  Anesthesiology       Date:  1956-05       Impact factor: 7.892

4.  Persistence of lung function abnormalities despite sustained success of percutaneous mitral valvotomy: the need for an early indication.

Authors:  Joan A Gómez-Hospital; Angel Cequier; Pablo V Romero; Concepción Cañete; Carmen Ugartemendia; Emili Iràculis; Enrique Esplugas
Journal:  Chest       Date:  2005-01       Impact factor: 9.410

5.  Stretching the effect of the balloon. Mitral valvuloplasty and pulmonary function.

Authors:  J A Bittl
Journal:  Chest       Date:  1990-08       Impact factor: 9.410

6.  Effects of valvular surgery on overall and regional lung function in patients with mitral stenosis.

Authors:  K Ohno; K Nakahara; H Hirose; S Nahano; Y Kawashima
Journal:  Chest       Date:  1987-08       Impact factor: 9.410

7.  [Early changes of respiratory function in mitral valve stenosis].

Authors:  C Rampulla; E Morbelli; G C Benza; S Amaducci
Journal:  G Ital Cardiol       Date:  1976

8.  Relation between severity of mitral valve disease and results of routine lung function tests in non-smokers.

Authors:  K M Rhodes; K Evemy; S Nariman; G J Gibson
Journal:  Thorax       Date:  1982-10       Impact factor: 9.139

9.  DISTURBANCES OF PULMONARY FUNCTION IN MITRAL VALVE DISEASE.

Authors:  W H PALMER; J B GEE; D V BATES
Journal:  Can Med Assoc J       Date:  1963-10-12       Impact factor: 8.262

10.  Early changes in pulmonary functions after mitral valve replacement.

Authors:  Pankaj Saxena; Suvitesh Luthra; Rajinder Singh Dhaliwal; Surinder Singh Rana; Digambar Behera
Journal:  Ann Thorac Med       Date:  2007-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.